Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. vs AARTI PHARMALABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIKAL. AARTI PHARMALABS HIKAL./
AARTI PHARMALABS
 
P/E (TTM) x 66.3 25.2 263.2% View Chart
P/BV x 4.1 3.3 125.5% View Chart
Dividend Yield % 0.3 0.5 64.1%  

Financials

 HIKAL.   AARTI PHARMALABS
EQUITY SHARE DATA
    HIKAL.
Mar-24
AARTI PHARMALABS
Mar-24
HIKAL./
AARTI PHARMALABS
5-Yr Chart
Click to enlarge
High Rs329595 55.2%   
Low Rs259272 95.1%   
Sales per share (Unadj.) Rs144.7204.4 70.8%  
Earnings per share (Unadj.) Rs5.623.9 23.6%  
Cash flow per share (Unadj.) Rs15.232.0 47.4%  
Dividends per share (Unadj.) Rs1.203.00 40.0%  
Avg Dividend yield %0.40.7 59.0%  
Book value per share (Unadj.) Rs96.3193.8 49.7%  
Shares outstanding (eoy) m123.3090.63 136.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.1 95.7%   
Avg P/E ratio x52.018.1 287.2%  
P/CF ratio (eoy) x19.313.5 142.8%  
Price / Book Value ratio x3.02.2 136.3%  
Dividend payout %21.312.5 169.6%   
Avg Mkt Cap Rs m36,20139,277 92.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,4651,280 192.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m17,84618,526 96.3%  
Other income Rs m2549 50.1%   
Total revenues Rs m17,87118,575 96.2%   
Gross profit Rs m2,6703,860 69.2%  
Depreciation Rs m1,176732 160.6%   
Interest Rs m564172 327.4%   
Profit before tax Rs m9553,005 31.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m259836 31.0%   
Profit after tax Rs m6962,169 32.1%  
Gross profit margin %15.020.8 71.8%  
Effective tax rate %27.127.8 97.5%   
Net profit margin %3.911.7 33.3%  
BALANCE SHEET DATA
Current assets Rs m9,66613,456 71.8%   
Current liabilities Rs m7,5666,944 109.0%   
Net working cap to sales %11.835.2 33.5%  
Current ratio x1.31.9 65.9%  
Inventory Days Days727 27.0%  
Debtors Days Days1131,023 11.0%  
Net fixed assets Rs m15,20512,365 123.0%   
Share capital Rs m247453 54.4%   
"Free" reserves Rs m11,63017,115 68.0%   
Net worth Rs m11,87717,568 67.6%   
Long term debt Rs m4,2290 1,084,233.3%   
Total assets Rs m24,87125,821 96.3%  
Interest coverage x2.718.5 14.6%   
Debt to equity ratio x0.40 1,603,818.8%  
Sales to assets ratio x0.70.7 100.0%   
Return on assets %5.19.1 55.9%  
Return on equity %5.912.3 47.5%  
Return on capital %9.418.1 52.1%  
Exports to sales %62.640.0 156.2%   
Imports to sales %19.814.0 141.7%   
Exports (fob) Rs m11,1677,419 150.5%   
Imports (cif) Rs m3,5282,585 136.5%   
Fx inflow Rs m11,1677,419 150.5%   
Fx outflow Rs m3,5282,585 136.5%   
Net fx Rs m7,6394,834 158.0%   
CASH FLOW
From Operations Rs m1,8672,164 86.3%  
From Investments Rs m-1,737-2,146 81.0%  
From Financial Activity Rs m-27097 -277.6%  
Net Cashflow Rs m-140115 -121.8%  

Share Holding

Indian Promoters % 68.9 45.9 149.9%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 10.4 18.7 55.3%  
FIIs % 6.8 7.4 91.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.2 53.9 57.8%  
Shareholders   71,912 185,436 38.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIKAL. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on HIKAL CHEMIC vs AARTI PHARMALABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

HIKAL CHEMIC vs AARTI PHARMALABS Share Price Performance

Period HIKAL CHEMIC AARTI PHARMALABS S&P BSE HEALTHCARE
1-Day 1.18% -3.30% 1.20%
1-Month 15.68% 5.15% 1.52%
1-Year 45.27% 56.00% 46.63%
3-Year CAGR -9.64% 18.90% 19.74%
5-Year CAGR 29.74% 10.95% 26.19%

* Compound Annual Growth Rate

Here are more details on the HIKAL CHEMIC share price and the AARTI PHARMALABS share price.

Moving on to shareholding structures...

The promoters of HIKAL CHEMIC hold a 68.9% stake in the company. In case of AARTI PHARMALABS the stake stands at 46.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of HIKAL CHEMIC and the shareholding pattern of AARTI PHARMALABS.

Finally, a word on dividends...

In the most recent financial year, HIKAL CHEMIC paid a dividend of Rs 1.2 per share. This amounted to a Dividend Payout ratio of 21.3%.

AARTI PHARMALABS paid Rs 3.0, and its dividend payout ratio stood at 12.5%.

You may visit here to review the dividend history of HIKAL CHEMIC, and the dividend history of AARTI PHARMALABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.